Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H27NO |
Molecular Weight | 309.4452 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(COC1=CC=CC=C1CC2=CC=CC=C2)N3CCCCC3
InChI
InChIKey=JTUQXGZRVLWBCR-UHFFFAOYSA-N
InChI=1S/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3
DescriptionSources: http://www.mims.com/hongkong/drug/info/cofrelCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16297353 and http://www.ncbi.nlm.nih.gov/pubmed/5301345
Sources: http://www.mims.com/hongkong/drug/info/cofrel
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16297353 and http://www.ncbi.nlm.nih.gov/pubmed/5301345
Benproperine (Cofrel) is a cough suppressant. It is used for symptomatic relief of cough. Cofrel is 2-4 times as potent as codeine in suppressing cough in animals. It acts peripherally by blocking afferent sensory nerve impulses originating from receptors in the lungs and pleura.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs. | 2004 Feb |
|
Identification of some benproperine metabolites in humans and investigation of their antitussive effect. | 2005 Dec |
|
Identification and quantitative determination of benproperine metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry. | 2006 Jan 2 |
|
[Nondestructive quantitative analysis of Cofrel medicines by improved partial least squares-NIR spectroscopy]. | 2007 Jun |
|
Resonance light scattering study on the interaction of benproperine phosphate with eriochrome blue black R in the presence of sodium dodecylbenzene sulphonate and its analytical application. | 2009 Mar-Apr |
Patents
Sample Use Guides
1 or 2 tablets 3 times daily, according to severity of cough. Tablets should be swallowed whole and not chewed.
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5301345
10(-5) g/ml of Benproperine (ASA 158/5) caused remarkable reduction of the contraction of the tracheal muscle preparation of a guinea pig caused
by histamine HCl.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QR05DB02
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
||
|
NCI_THESAURUS |
C66917
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
||
|
WHO-ATC |
R05DB02
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB13309
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
5236
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
C477447
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
37560
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
2156-27-6
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
2326
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
BENPROPERINE
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
m2321
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
C78103
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
DTXSID10862853
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
3118
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
SUB05728MIG
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
100000086375
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
236749
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL2105910
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY | |||
|
3AA6IZ48YK
Created by
admin on Fri Dec 15 16:05:51 GMT 2023 , Edited by admin on Fri Dec 15 16:05:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)